# Vitamin B12 Deficiency: Evidence-Based Guide
Canonical: https://www.migaku.app/guides/vitamin-b12-guide
Category: ai-evidence-guide
Summary: Vitamin B12 deficiency affects 5.2 to 6.3% of Australians over 50 and can manifest as pseudo-thrombotic microangiopathy in 2.5% of cases [Source 1][Source 2].
Last reviewed: 2026-06-26
Reviewed by: Migaku AI Evidence Review
## Quick Answer
Vitamin B12 deficiency affects 5.2 to 6.3% of Australians over 50 and can manifest as pseudo-thrombotic microangiopathy in 2.5% of cases [Source 1][Source 2].

## Key Takeaways
- Vitamin B12 deficiency prevalence is 5.2 to 6.3% in Australians over 50, with higher rates in certain refugee populations (20 to 30%) [Source 1].
- Diagnosis is complex due to unreliable standalone tests; total serum B12 is the first-line test, with active B12 or methylmalonic acid tests used if results are indeterminate [Source 1].
- Pseudo-thrombotic microangiopathy occurs in 2.5% of B12 deficiency cases, mimicking thrombotic thrombocytopenic purpura [Source 2].
- Laboratory findings in pseudo-TMA include low B12 levels (e.g., 121 pg/mL), pancytopenia, and LDH levels >2500 units/L [Source 2].
- Risk factors include inadequate dietary intake and malabsorptive conditions [Source 1].

## Clinical Evidence Deep-Dive
Vitamin B12 deficiency diagnosis relies on a combination of clinical signs and biochemical tests. Bedz Darya's narrative review emphasizes the use of total serum B12 as the primary test, supplemented by active B12 or methylmalonic acid tests when results are inconclusive. The prevalence in Australians over 50 is 5.2 to 6.3%, with certain refugee groups experiencing rates as high as 20 to 30% [Source 1]. The review highlights the diagnostic challenge due to the lack of a universally reliable test, necessitating a comprehensive approach that considers symptoms and risk factors.

Bertucci HK's research article presents a case of pseudo-thrombotic microangiopathy (pseudo-TMA) in a patient with longstanding oral B12 supplementation. This condition, occurring in 2.5% of B12 deficiency cases, mimics thrombotic thrombocytopenic purpura. The case involved a 45-year-old female with symptoms such as fatigue and bleeding, with laboratory findings showing low B12 levels (121 pg/mL), pancytopenia, and elevated LDH levels (>2500 units/L) [Source 2]. These findings underscore the importance of considering pseudo-TMA in differential diagnoses of anemia and related symptoms.

The narrative review and case report collectively illustrate the complexity of diagnosing and managing B12 deficiency. The narrative review provides a broad overview of diagnostic strategies, while the case report offers detailed insights into specific manifestations like pseudo-TMA. Both sources highlight the need for a multifaceted diagnostic approach, integrating clinical evaluation with biochemical testing.

## Practical Protocol
Clinical reference - consult a physician: For suspected vitamin B12 deficiency, initiate testing with total serum B12. If results are indeterminate, consider active B12 or methylmalonic acid tests. In cases of confirmed deficiency, treatment typically involves oral B12 supplementation or intramuscular injections, with dosages tailored to the severity of deficiency and patient response.

## FAQ
**What are common symptoms of vitamin B12 deficiency?**
Symptoms include fatigue, anemia, and neurological issues. In rare cases (2.5%), it can present as pseudo-thrombotic microangiopathy with symptoms like bleeding and bruising [Source 2].

**How is vitamin B12 deficiency diagnosed?**
Diagnosis involves total serum B12 testing, with additional tests like active B12 or methylmalonic acid if initial results are inconclusive [Source 1].

**Who is at higher risk for vitamin B12 deficiency?**
Individuals over 50, certain refugee populations, and those with inadequate dietary intake or malabsorptive conditions are at higher risk [Source 1].

## References
[1] Vitamin B12 deficiency: testing and treatment. Bedz Darya. 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC13095491/

[2] Vitamin B12 Deficiency-Associated Pseudo-Thrombotic Microangiopathy in a Patient on Longstanding Oral B12 Supplementation. Bertucci HK. 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC13091720/